You are cordially invited to Festo's press meeting with C. Gerhardt at Analytica
mehr
Ergebnis der Suchanfrage nach Celle
Inhalte
- Kategorie:
- Sprache:
- Medien:
- Zeitraum:
- Zeitraum:Gesamt
603 Treffer
Scientists Reveal Adipocyte's Metabolic Role and Identify Treatment Targets
mehrARTCLINE successfully completes capital increases of EUR 4.4 million
Rostock, Germany (ots) - Today ARTCLINE GmbH announced the successful completion of two further capital increases. In addition to the founders, in particular family offices from Germany participated in the first capital increase of EUR 0.8 million. In addition, a convertible loan from investors was transferred to equity, so that a second capital increase of EUR 3.6 ...
mehr- 4
Technological milestone in the new food industry: GEA presents perfusion as key process at Anuga FoodTec
Ein Dokumentmehr Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand
Research Triangle Park, N.C. and Uxbridge, England (ots/PRNewswire) - Agreement pairs Norgine's commercial expertise and leading European footprint with PEDMARQSI™, the first and only approved therapy in the European Union and U.K. for reducing the risk of cisplatin-induced hearing loss in pediatric patients with ...
mehrCustomCells founds U.S. subsidiary with Detroit site
mehr
Invitation to press briefing at Anuga FoodTec 2024: Discover the Future of New Food Production
mehrInvitation to press briefing at Anuga FoodTec 2024: Discover the Future of New Food Production
mehr- 9
Football fans from Europe visit the champion of structural change in Gelsenkirchen
Ein Dokumentmehr Research Success in Rare Disease / RHEACELL receives positive signal for accelerated stem cell development program in rare ‚Butterfly Disease‘
mehrRising Focus on 'Inceptor' as a Type 2 Diabetes Therapeutic Target
mehrAston Martin Lagonda of Europe GmbH
10New Aston Martin Vantage GT4 completes top-flight line-up of production-based GT racers
mehr
- 4
GEA at the Anuga FoodTec trade show: Sustainability innovations bolster food industry resilience
Ein Dokumentmehr Therapeutic Vaccine for Chronic Hepatitis B Enters Clinical Trial
mehrWhat Our Genetic Information Tells Us About Type 2 Diabetes Risk and Complications
mehrHearing loss company Acousia announces first patient enrolled in its Phase 2 PROHEAR-Study
Tübingen, Germany (ots) - Acousia Therapeutics GmbH, a Tübingen-based clinical stage biotech company focused on the enhancement and preservation of natural hearing, just announced the randomization of the first patient for the PROHEAR-Study. The PROHEAR-Study is a placebo-controlled, Phase 2a study with split-body design, which investigates the otoprotective efficacy ...
mehr- 3
GEA invests EUR 18 million in technology center for alternative proteins in the USA
Ein Dokumentmehr Aston Martin Lagonda of Europe GmbH
10STATE-OF-THE-ART ASTON MARTIN VANTAGE GT3 SPEARHEADS NEW ERA IN TOP-FLIGHT GT RACING
mehr
- 2
PM: DHL Group mit Wasserstoff-LKWs im Rheinland unterwegs / PR: DHL Group deploying hydrogen trucks in Germany
2 Dokumentemehr Strengthening the Direct Sales and Service System for Business Expansion in Italy
Ein DokumentmehrBiomay Announces its Successful Support of Approval of First CRISPR/Cas9-based Therapy
mehrHigh-tech fab in Dresden receives state-of-the-art electron-beam lithography system
Jena (ots) - Investment in new production tool for the semiconductor equipment industry. Jenoptik is investing a low double-digit million-euro amount in a state-of-the-art system for the high-tech fab currently under construction in Dresden. The new electron-beam lithography system (E-Beam) will be used to manufacture high-precision micro-optical components for ...
mehrPress release: STADA and Alvotech secure approval for Uzpruvo, Europe’s first ustekinumab biosimilar to Stelara
STADA and Alvotech secure approval for Uzpruvo, Europe’s first ustekinumab biosimilar to Stelara - Marketing authorization issued in European Economic Area for Uzpruvo®, the first biosimilar to Stelara®, a biologic therapy within ...
Ein DokumentmehrAcousia Therapeutics attracts new investor on its path to make hearing loss a treatable disease
Tübingen (ots) - - German pioneer biotech accelerates hearing loss solution development with fresh capital boost Acousia Therapeutics GmbH, a clinical-stage biotech company developing drug candidates against acute and chronic forms of hearing loss, proudly announces Esperante Ventures as the latest addition to its esteemed group of investors. The infusion of fresh ...
mehr
Cells of the Future: A Key To Reprogramming Cell Identities
mehrNew Source of Stem Cells in Injury-Affected Brains of Patients
mehrEnergy at its best: German battery pioneer CustomCells unveils new brand identity
mehrFraunhofer-Institut für Produktionstechnologie IPT
Pooling expertise: Fraunhofer IPT and Harro Höfliger cooperate in the manufacturing of ATMP production systems
mehrTen benefits of a daily intake of citrus fruits during winter season
mehrBiomay Announces Expansion of GMP-Facilities to Offer mRNA Manufacturing and Aseptic Filling Services
mehr
Vorherige12345678910Nächste